Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4764
Source ID: NCT01382303
Associated Drug: Pentoxifylline
Title: Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01382303/results
Conditions: Type 2 Diabetes
Interventions: DRUG: Pentoxifylline|DRUG: Placebo
Outcome Measures: Primary: Percentage Change in Proteinuia, Changes of urine protein to creatinie ratio from baseline to 24 weeks, baseline and 24 weeks | Secondary: Percentage Change in Albuminuria, Changes of urine albumin to creatinie ratio from baseline to 24 weeks, baseline and 24 weeks|Mean Change of eGFR, changes in eGFR from baseline to 24 weeks, baseline and 24 weeks|Mean Change of Creatinine, changes serum creatinine from baseline to 24 weeks, baseline and 24 weeks|Mean Change of Fasting Glucose, changes serum fasting glucose from baseline to 24 weeks, baseline and 24 weeks|Mean Change of TNF-a, changes in TNF-a from baseline to 24 weeks, baseline and 24 weeks
Sponsor/Collaborators: Sponsor: Ajou University School of Medicine | Collaborators: Bundang CHA Hospital|Hallym University Medical Center|Gangnam Severance Hospital|Yonsei University|Myongji Hospital
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 174
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2010-10-25
Completion Date: 2013-12-20
Results First Posted: 2017-06-16
Last Update Posted: 2017-06-16
Locations: Ajou University Hospital, Suwon, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT01382303